Hardcover. Condizione: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.
Hardcover. Condizione: Very Good.
EUR 9,29
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: As New. Leichte Kratzer / Abnutzungen / Druckstellen. The Society for Immunotherapy of Cancer's handbook, SITC's Guide to Managing Immunotherapy Toxicity, serves as a practical reference for managing side effects linked to FDA-approved cancer immunotherapy drugs. It is divided into two parts: Part I offers chapter-based overviews of immune checkpoint inhibitors, including anti-CTLA4 and anti-PD1/PD-L1 agents, along with approved combinations. These chapters detail mechanisms of action, indications, and toxicities encountered in early, advanced, and metastatic cancer patients. Part II focuses on common and uncommon toxicities affecting major organ sites. It begins with a general summary of management principles, followed by specific chapters on toxicities such as rash, mucosal irritation, joint and muscle toxicity, diarrhea, pneumonitis, endocrine, neurological, cardiac, renal, hematologic, and ocular toxicities. Each chapter provides guidance on assessing and treating these toxicities, with detailed summary tables for quick reference. Additionally, Part II addresses the management of special patient populations, including those with autoimmune diseases and geriatric patients, as well as treatment for fatigue and the financial impact of care. Written by leading experts in immuno-oncology, this text is an essential resource for clinical oncologists, emergency physicians, and other medical practitioners in both hospital and community settings, especially as immune checkpoint inh.
Condizione: good. This book is in good condition, with minimal signs of wear and tear.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: Acceptable. SHIPS FAST. RESCUED + REPAIRED. Features a small coffee mishap, plus a reinforced binding, secured cover, and light annotations or highlighting-a durable, fully readable working copy brought back to life at a great value by our Book Sustainability Project. No access codes or CDs.
EUR 68,43
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 70,78
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
EUR 70,18
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
EUR 89,11
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 270.
Lingua: Inglese
Editore: Elsevier Science Health Science, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: Revaluation Books, Exeter, Regno Unito
EUR 84,48
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 255 pages. 9.00x7.50x0.75 inches. In Stock.
Da: Revaluation Books, Exeter, Regno Unito
EUR 91,33
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st pap/psc edition. 246 pages. 8.00x5.00x0.65 inches. In Stock.
Condizione: New. pp. 270.
EUR 100,76
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New. pp. 270.
Lingua: Inglese
Editore: Elsevier - Health Sciences Division, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: THE SAINT BOOKSTORE, Southport, Regno Unito
EUR 98,72
Quantità: Più di 20 disponibili
Aggiungi al carrelloPaperback / softback. Condizione: New. New copy - Usually dispatched within 4 working days.
EUR 113,93
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: New. pp. xix + 741 Illus.
EUR 70,71
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that af.
Condizione: New. pp. xix + 741 Index.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
EUR 108,54
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
EUR 85,85
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Immune Checkpoint Inhibitors in Cancer | Fumito Ito (u. a.) | Taschenbuch | Englisch | 2018 | Elsevier Health Sciences | EAN 9780323549486 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
Lingua: Inglese
Editore: Springer Publishing Company Mär 2019, 2019
ISBN 10: 0826172148 ISBN 13: 9780826172143
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 95,13
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that affect major organ sites throughout the body.
EUR 147,90
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 83,90
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Elsevier Health Sciences Aug 2018, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 90,99
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource. 270 pp. Englisch.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 102,89
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource.